MENU
+Compare
RNAC
Stock ticker: NASDAQ
AS OF
Jan 17, 04:59 PM (EDT)
Price
$19.40
Change
+$0.47 (+2.48%)
Capitalization
496.24M

RNAC Cartesian Therapeutics Forecast, Technical & Fundamental Analysis

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RNAC with price predictions
Jan 14, 2025

RNAC sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for RNAC moved below the 200-day moving average on December 31, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 31, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RNAC as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for RNAC crossed bearishly below the 50-day moving average on December 23, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RNAC entered a downward trend on January 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where RNAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RNAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RNAC's P/B Ratio (666.667) is very high in comparison to the industry average of (15.339). P/E Ratio (0.000) is within average values for comparable stocks, (87.552). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.851). RNAC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1.998) is also within normal values, averaging (263.778).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RNAC is expected to report earnings to fall 40.00% to -89 cents per share on May 09

Cartesian Therapeutics RNAC Stock Earnings Reports
Q1'24
Est.
$-0.90
Q4'23
Missed
by $1.47
Q3'23
Missed
by $1.28
Q2'23
Beat
by $0.01
Q1'23
Missed
by $4.11
The last earnings report on March 07 showed earnings per share of -150 cents, missing the estimate of -2 cents. With 64.46K shares outstanding, the current market capitalization sits at 496.24M.
A.I. Advisor
published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

RNAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-0.11%
WINT - RNAC
94%
Closely correlated
-6.63%
NCNA - RNAC
92%
Closely correlated
+2.77%
CDTX - RNAC
92%
Closely correlated
+4.06%
NBY - RNAC
91%
Closely correlated
+2.90%
SNPX - RNAC
91%
Closely correlated
-5.44%
More

Groups containing RNAC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-0.11%
RNAC
(19 stocks)
48%
Loosely correlated
+0.99%